At a glance
- Originator Chiron Corporation
- Class Antibacterials
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 27 Jan 2000 Preclinical development for Bacterial infections in USA (Unknown route)